Post Categories
CLIA Regulations During the COVID-19 Pandemic
July 13, 2020
During the ongoing pandemic, all COVID-19-related testing used for the diagnosis, prevention, or treatment of disease, or for a health assessment, must adhere to…
Flortaucipir PET Shows Promise in Alzheimer’s Disease Diagnosis
July 1, 2020
In the April 27th issue of JAMA Neurology, researchers released new data that suggests 18F-flortaucipir positron emission topography (PET) can help clinicians diagnose late-stage Alzheimer’s Disease…
Repetitive Negative Thinking Linked to Alzheimer’s Disease
June 29, 2020
According to a study published in Alzheimer’s & Dementia, cognitive decline and the deposition of harmful proteins in the brain linked to Alzheimer’s Disease…
Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
June 22, 2020
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge,…
Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
June 15, 2020
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many…
FDA Guidance Documents for COVID-19
June 10, 2020
COVID-19 was declared a global pandemic on March 11, 2020. As the novel coronavirus continues to dominate headlines and impact communities around the globe,…
Protein Shapes in Alzheimer’s Disease Research
June 8, 2020
Proteins — large molecules made up of amino acids — do most of the work in cells and are required for the structure, function,…
Early Detection of Alzheimer’s Disease Through exRNA Biomarkers
June 1, 2020
Alzheimer’s Disease (AD), a progressive neurodegenerative disease, is estimated to affect around 50 million people worldwide. AD is most prevalent in North America and…
Can Llama Antibodies Help Fight SARS-CoV-2?
May 28, 2020
Winter is a llama who lives on a farm in Ghent, Belgium — and she may be a vital figure in the fight against…
Racing Against the Clock: Developing Monoclonal Antibodies During a Pandemic
May 26, 2020
Between the current SARS-CoV-2 pandemic and the SARS, H1N1 and HIV/AIDS epidemics all taking place within the last 50 years, major infectious disease outbreaks…
Novel Coronavirus Testing: Part IV
May 18, 2020
Saliva Testing Accurate, rapid testing for the novel coronavirus (SARS-CoV-2) is crucial to controlling the COVID-19 pandemic. In previous installments of this blog series,…
Novel Coronavirus Testing: Part III
May 6, 2020
Antigen Testing Part I of this series on testing for the novel coronavirus covered the real-time reverse transcription polymerase chain reaction (rRT-PCR) assay, which…
The Modern Quest for the Fountain of Youth
January 9, 2023
Quests for anti-aging solutions, usually the stuff of science fiction, have been revived with research into cellular reprogramming. More than 15 years ago, researchers…
Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021,…
Offering Pain Relief Without Opioids, Vertex’s Sodium Channel Blocker Advances
December 12, 2022
Opioid pain relievers are highly addictive, contributing to high rates of opioid use disorder and overdose. According to the World Health Organization, opioid use…
Children with Retinitis Pigmentosa to See the World
December 7, 2022
Retinitis pigmentosa is a degenerative eye condition that slowly destroys the retina, the light-sensitive tissue at the back of the eye. For Canadian couple…
Reporting Live From the Brain — Tiny Microscope Tracks Activity in Moving Mice
December 5, 2022
Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain…
From Cultural Rite to Clinical Trial — Examining the Therapeutic Potential of Mescaline
November 28, 2022
Psychedelics are having a moment, as researchers, startups, and regulators are recognizing the potential of these previously stigmatized compounds for treating mental health disorders….
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
NEWARK, Delaware, November 13, 2024/BUSINESS WIRE/ — QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy…
